PML and breast cancer: However, Pml−/− mice treated with the DMBA-TPA protocol, while showing increased papilloma incidence, develop few more malignant tumors, and Tsc2± and MMTV neu driven kidney and mammary tumors, respectively, do not show differences in tumor initiation.